Nome |
# |
Protein corona and nanoparticles: How can we investigate on?, file e31e124c-78c5-987f-e053-3705fe0a095a
|
1.102
|
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art, file e31e124d-13a1-987f-e053-3705fe0a095a
|
834
|
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin, file e31e124b-eba1-987f-e053-3705fe0a095a
|
705
|
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders, file e31e124d-2485-987f-e053-3705fe0a095a
|
464
|
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery, file e31e124d-11fc-987f-e053-3705fe0a095a
|
372
|
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog, file e31e1250-0de5-987f-e053-3705fe0a095a
|
370
|
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study, file e31e124a-ab87-987f-e053-3705fe0a095a
|
356
|
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA), file e31e1250-1aed-987f-e053-3705fe0a095a
|
346
|
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes, file e31e124b-2b29-987f-e053-3705fe0a095a
|
307
|
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system, file e31e124c-7852-987f-e053-3705fe0a095a
|
303
|
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry, file e31e124e-9bdc-987f-e053-3705fe0a095a
|
263
|
Nanoparticle transport across the blood brain barrier, file e31e124b-fd98-987f-e053-3705fe0a095a
|
254
|
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study, file e31e124e-7abd-987f-e053-3705fe0a095a
|
235
|
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice, file e31e124b-2850-987f-e053-3705fe0a095a
|
216
|
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders, file e31e124b-c7b2-987f-e053-3705fe0a095a
|
203
|
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD, file e31e1250-5e69-987f-e053-3705fe0a095a
|
194
|
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity, file e31e124b-e9b6-987f-e053-3705fe0a095a
|
182
|
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol, file e31e124e-9d53-987f-e053-3705fe0a095a
|
178
|
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog, file e31e124e-e21f-987f-e053-3705fe0a095a
|
177
|
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles, file e31e124b-2afe-987f-e053-3705fe0a095a
|
175
|
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences., file e31e124a-ae80-987f-e053-3705fe0a095a
|
136
|
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications, file e31e124e-73fa-987f-e053-3705fe0a095a
|
118
|
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment, file e31e124e-8939-987f-e053-3705fe0a095a
|
116
|
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain, file e31e124b-fe37-987f-e053-3705fe0a095a
|
107
|
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting, file e31e1250-aac7-987f-e053-3705fe0a095a
|
58
|
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles, file e31e124c-47de-987f-e053-3705fe0a095a
|
45
|
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124d-a1f5-987f-e053-3705fe0a095a
|
36
|
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles, file e31e124a-a629-987f-e053-3705fe0a095a
|
22
|
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol, file e31e1250-668c-987f-e053-3705fe0a095a
|
20
|
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes, file e31e124a-b003-987f-e053-3705fe0a095a
|
13
|
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE, file e31e124a-af12-987f-e053-3705fe0a095a
|
9
|
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release, file e31e124a-a708-987f-e053-3705fe0a095a
|
7
|
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting, file e31e124b-3178-987f-e053-3705fe0a095a
|
6
|
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments, file e31e124b-3144-987f-e053-3705fe0a095a
|
5
|
Evidence of the existence of 2:1 guest-host complexes between diclofenac and cyclodextrins in D2O solutions. A 1H and 13C NMR study on diclofenac/beta-cyclodextrin and diclofenac/2-hydroxypropyl-beta-cyclodextrin systems, file e31e124a-96d8-987f-e053-3705fe0a095a
|
4
|
Colloidal systems for CNS drug delivery, file e31e124a-a126-987f-e053-3705fe0a095a
|
4
|
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation, file e31e124a-a570-987f-e053-3705fe0a095a
|
4
|
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents., file e31e124a-a619-987f-e053-3705fe0a095a
|
4
|
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma, file e31e124a-aa8a-987f-e053-3705fe0a095a
|
4
|
Sialic Acid as a potential approach for the protection and targeting of nanocarriers, file e31e124a-af06-987f-e053-3705fe0a095a
|
4
|
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts, file e31e124b-3111-987f-e053-3705fe0a095a
|
4
|
Dotap/Udca vesicles: novel approach in oligonucleotide delivery, file e31e124a-9827-987f-e053-3705fe0a095a
|
3
|
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution, file e31e124a-a50d-987f-e053-3705fe0a095a
|
3
|
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach, file e31e124c-e424-987f-e053-3705fe0a095a
|
3
|
Protein corona and nanoparticles: How can we investigate on?, file e31e124f-e216-987f-e053-3705fe0a095a
|
3
|
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123, file e31e124a-99cb-987f-e053-3705fe0a095a
|
2
|
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures, file e31e124a-9e25-987f-e053-3705fe0a095a
|
2
|
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation, file e31e124a-a04b-987f-e053-3705fe0a095a
|
2
|
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport, file e31e124a-a50e-987f-e053-3705fe0a095a
|
2
|
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier., file e31e124a-a9a5-987f-e053-3705fe0a095a
|
2
|
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells, file e31e124a-aa41-987f-e053-3705fe0a095a
|
2
|
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences., file e31e124a-ab86-987f-e053-3705fe0a095a
|
2
|
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum, file e31e124a-b001-987f-e053-3705fe0a095a
|
2
|
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury, file e31e124b-29f0-987f-e053-3705fe0a095a
|
2
|
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots, file e31e124b-2af5-987f-e053-3705fe0a095a
|
2
|
Nanotechnology and Alzheimer’s disease: What has been done and what to do’, file e31e124b-2ba1-987f-e053-3705fe0a095a
|
2
|
Nanomedicine and neurodegenerative disorders: So close yet so far, file e31e124b-2f6e-987f-e053-3705fe0a095a
|
2
|
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124b-30fd-987f-e053-3705fe0a095a
|
2
|
Effect of the loading method on the drug release from cross-linked carboxymethylcellulose beads, file e31e124b-e95f-987f-e053-3705fe0a095a
|
2
|
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain, file e31e124b-e9bc-987f-e053-3705fe0a095a
|
2
|
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study, file e31e124d-f46e-987f-e053-3705fe0a095a
|
2
|
Cationic liposomes for gene transfection, file e31e124a-9515-987f-e053-3705fe0a095a
|
1
|
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives, file e31e124a-960e-987f-e053-3705fe0a095a
|
1
|
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes, file e31e124a-9784-987f-e053-3705fe0a095a
|
1
|
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells, file e31e124a-97a7-987f-e053-3705fe0a095a
|
1
|
Microwave-treated gelatin microspheres as drug delivery system, file e31e124a-9e75-987f-e053-3705fe0a095a
|
1
|
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles, file e31e124a-9e89-987f-e053-3705fe0a095a
|
1
|
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier, file e31e124a-9ece-987f-e053-3705fe0a095a
|
1
|
Polymeric nanoparticles for the drug delivery to the central nervous system, file e31e124a-9fc8-987f-e053-3705fe0a095a
|
1
|
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells, file e31e124a-a049-987f-e053-3705fe0a095a
|
1
|
Biodegradable device applied in flatfoot surgery: Comparative studies between
clinical and technological aspects of removed screws, file e31e124a-a317-987f-e053-3705fe0a095a
|
1
|
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts., file e31e124a-aa3d-987f-e053-3705fe0a095a
|
1
|
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study, file e31e124a-aa89-987f-e053-3705fe0a095a
|
1
|
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier, file e31e124a-ad08-987f-e053-3705fe0a095a
|
1
|
Oral delivery of insulin loaded into polymeric nanoparticles in rats., file e31e124a-ae84-987f-e053-3705fe0a095a
|
1
|
Nanoparticles for brain delivery of drugs: in vivo experiments and mechanism of BBB crossing, file e31e124a-af11-987f-e053-3705fe0a095a
|
1
|
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?, file e31e124a-b009-987f-e053-3705fe0a095a
|
1
|
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution, file e31e124a-b153-987f-e053-3705fe0a095a
|
1
|
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles, file e31e124b-0b5a-987f-e053-3705fe0a095a
|
1
|
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma, file e31e124b-29ee-987f-e053-3705fe0a095a
|
1
|
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo, file e31e124b-3140-987f-e053-3705fe0a095a
|
1
|
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury, file e31e124b-3149-987f-e053-3705fe0a095a
|
1
|
Comparison between Roesy and C-13 NMR complexation shifts in deriving the geometry of inclusion compounds: A study on the interaction between hyodeoxycholic acid and 2-hydroxypropyl-beta-cyclodextrin, file e31e124b-e05d-987f-e053-3705fe0a095a
|
1
|
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs, file e31e124b-e48c-987f-e053-3705fe0a095a
|
1
|
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity, file e31e124b-e820-987f-e053-3705fe0a095a
|
1
|
Montmorillonite come "carrier" nella deposizione superficiale di farmaci, file e31e124b-e9a8-987f-e053-3705fe0a095a
|
1
|
Surface area and crystallinity of Form A of chloramphenicol palmitic and stearic esters: which one is the limiting factor in the enzymatic hydrolysis?, file e31e124b-f108-987f-e053-3705fe0a095a
|
1
|
Functionalization of liposomes: microscopical methods for preformulative screening, file e31e124b-fd5f-987f-e053-3705fe0a095a
|
1
|
Cristallinità ed equivalenza nel cloramfenicolo palmitato, file e31e124d-7e7d-987f-e053-3705fe0a095a
|
1
|
Totale |
8.034 |